How can you advise patients taking ruxolitinib for vitiligo on looking for signs of repigmentation?

Featuring Cheri Frey, MD | Assistant Professor, Dermatology & Residency Program Director Director of Cosmetic DermatologyHoward UniversityWashington, DC | Published June 01, 2024